Dynamics of immune escape during HIV/SIV infection

PLoS Computational Biology

Volumn 4, Issue 7, 2008, Pages

  Althaus, Christian L ^a   De Boer, Rob J ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CLONING; DISEASES; EPITOPES; IMMUNE SYSTEM; VIRUSES;

CELLULARS; COMPUTATIONAL MODELLING; CYTOTOXIC; CYTOTOXIC T LYMPHOCYTES; IMMUNE RESPONSE; IMMUNODOMINANCE; INFECTED CELLS; SELECTIVE PRESSURE; VIRUS DYNAMICS; VIRUS POPULATION;

VACCINES;

ARTICLE; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MATHEMATICAL MODEL; NONHUMAN; RETROVIRUS INFECTION; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS IMMUNITY; VIRUS INHIBITION; VIRUS LOAD; VIRUS REPLICATION; ANIMAL; BIOLOGICAL MODEL; CYTOTOXICITY; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOLOGY; KINETICS; MONKEY DISEASE; MUTATION; VIROLOGY;

EPITOPE; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; VIRUS ANTIGEN;

ANIMALS; ANTIGENS, VIRAL; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES, T-LYMPHOCYTE; HIV; HIV ANTIGENS; HIV INFECTIONS; HUMANS; IMMUNODOMINANT EPITOPES; KINETICS; MODELS, IMMUNOLOGICAL; MUTATION; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS REPLICATION;

EID: 48249088137     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1000103     Document Type: Article

References (50)

1. Kaslow R, Carrington M, Apple R, Park L, Munoz A, et al. (1996) Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med 2: 405-11.
2. Schmitz J, Kuroda M, Santra S, Sasseville V, Simon M, et al. (1999) Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 283: 857-60.
3. Friedrich T, Dodds E, Yant L, Vojnov L, Rudersdorf R, et al. (2004) Reversion of CTL escape-variant immunodeficiency viruses in vivo. Nat Med 10: 275-81.
4. Barouch D, Powers J, Truitt D, Kishko M, Arthur J, et al. (2005) Dynamic immune responses maintain cytotoxic T lymphocyte epitope mutations in transmitted simian immunodeficiency virus variants. Nat Immunol 6: 247-52.
5. Kent S, Fernandez C, Dale C, Davenport M (2005) Reversion of immune escape HIV variants upon transmission: insights into effective viral immunity. Trends Microbiol 13: 243-6.
6. Peut V, Kent S (2006) Fitness constraints on immune escape from HIV: Implications of envelope as a target for both HIV-specific T cells and antibody. Curr HIV Res 4: 191-7.
7. Crawford H, Prado J, Leslie A, Hue S, Honeyborne I, et al. (2007) Compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant HLA-B*5703-restricted Gag epitope in chronic human immunodeficiency virus type 1 infection. J Virol 81: 8346-51.
8. Frater A, Brown H, Oxenius A, Gunthard H, Hirschel B, et al. (2007) Effective T-cell responses select human immunodeficiency virus mutants and slow disease progression. J Virol 81: 6742-51.
9. Li B, Gladden A, Altfeld M, Kaldor J, Cooper D, et al. (2007) Rapid reversion of sequence polymorphisms dominates early human immunodeficiency virus type 1 evolution. J Virol 81: 193-201.
10. Phillips R, Rowland-Jones S, Nixon D, Gotch F, Edwards J, et al. (1991) Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 354: 453-9.
11. Goulder P, Watkins D (2004) HIV and SIV CTL escape: implications for vaccine design. Nat Rev Immunol 4: 630-40.
12. Asquith B, Edwards C, Lipsitch M, McLean A (2006) Inefficient cytotoxic T lymphocyte- mediated killing of HIV-1-infected cells in vivo. PLoS Biol 4: e90.
13. Asquith B, McLean A (2007) In vivo CD8+ T cell control of immunodeficiency virus infection in humans and macaques. Proc Natl Acad Sci U S A 104: 6365-70.
14. Loh L, Batten C, Petravic J, Davenport M, Kent S (2007) In vivo fitness costs of different Gag CD8 T-cell escape mutant simian-human immunodeficiency viruses for macaques. J Virol 81: 5418-22.
15. Mandl J, Regoes R, Garber D, Feinberg M (2007) Estimating the effectiveness of SIV-specific CD8+ T cells from the dynamics of viral immune escape. J Virol 81: 11982-91.
16. Ganusov V, De Boer R (2006) Estimating costs and benefits of CTL escape mutations in SIV/HIV infection. PLoS Comput Biol 2: e24.
17. Goulder P, Phillips R, Colbert R, McAdam S, Ogg G, et al. (1997) Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat Med 3: 212-7.
18. Allen T, O'Connor D, Jing P, Dzuris J, Mothe B, et al. (2000) Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia. Nature 407: 386-90.
19. Cao J, McNevin J, Malhotra U, McElrath M (2003) Evolution of CD8+ T cell immunity and viral escape following acute HIV-1 infection. J Immunol 171: 3837-46.
20. Altfeld M, Rosenberg E, Shankarappa R, Mukherjee J, Hecht F, et al. (2001) Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection. J Exp Med 193: 169-80.
21. Draenert R, Allen T, Liu Y, Wrin T, Chappey C, et al. (2006) Constraints on HIV-1 evolution and immunodominance revealed in monozygotic adult twins infected with the same virus. J Exp Med 203: 529-39.
22. Karlsson A, Iversen A, Chapman J, de Oliviera T, Spotts G, et al. (2007) Sequential broadening of CTL responses in early HIV-1 infection is associated with viral escape. PLoS ONE 2: e225.
23. Kouyos R, Althaus C, Bonhoeffer S (2006) Stochastic or deterministic: what is the effective population size of HIV-1? Trends Microbiol 14: 507-11.
24. Kelleher A, Long C, Holmes E, Allen R, Wilson J, et al. (2001) Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. J Exp Med 193: 375-86.
25. Nowak M, May R (2000) Virus Dynamics: Mathematical Principles of Immunology and Virology. Oxford: Oxford Univerity Press.
26. Perelson A (2002) Modelling viral and immune system dynamics. Nat Rev Immunol 2: 28-36.
27. Nowak M, May R, Phillips R, Rowland-Jones S, Lalloo D, et al. (1995) Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nature 375: 606-11.
28. De Boer R (2007) Understanding the failure of CD8+ T-cell vaccination against simian/human immunodeficiency virus. J Virol 81: 2838-48.
29. Ramratnam B, Bonhoeffer S, Binley J, Hurley A, Zhang L, et al. (1999) Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis. Lancet 354: 1782-5.
30. De Boer R, Perelson A (1998) Target cell limited and immune control models of HIV infection: a comparison. J Theor Biol 190: 201-14.
31. Geels M, Cornelissen M, Schuitemaker H, Anderson K, Kwa D, et al. (2003) Identification of sequential viral escape mutants associated with altered T-cell responses in a human immunodeficiency virus type 1-infected individual. J Virol 77: 12430-40.
32. Haase A, Henry K, Zupancic M, Sedgewick G, Faust R, et al. (1996) Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science 274: 985-9.
33. Davenport M, Ribeiro R, Perelson A (2004) Kinetics of virus-specific CD8+ T cells and the control of human immunodeficiency virus infection. J Virol 78: 10096-103.
34. Phillips A (1996) Reduction of HIV concentration during acute infection: independence from a specific immune response. Science 271: 497-9.
35. Li Q, Duan L, Estes J, Ma Z, Rourke T, et al. (2005) Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature 434: 1148-52.
36. Mattapallil J, Douek D, Hill B, Nishimura Y, Martin M, et al. (2005) Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 434: 1093-7.
37. Bonhoeffer S, Funk G, Gunthard H, Fischer M, Muller V (2003) Glancing behind virus load variation in HIV-1 infection. Trends Microbiol 11: 499-504.
38. Fernandez C, Stratov I, De Rose R, Walsh K, Dale C, et al. (2005) Rapid viral escape at an immunodominant simian-human immunodeficiency virus cytotoxic T-lymphocyte epitope exacts a dramatic fitness cost. J Virol 79: 5721-31.
39. Regoes R, Yates A, Antia R (2007) Mathematical models of cytotoxic T-lymphocyte killing. Immunol Cell Biol 85: 274-9.
40. Yu X, Addo M, Rosenberg E, Rodriguez W, Lee P, et al. (2002) Consistent patterns in the development and immunodominance of human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T-cell responses following acute HIV-1 infection. J Virol 76: 8690-701.
41. Ogg G, Jin X, Bonhoeffer S, Moss P, Nowak M, et al. (1999) Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy. J Virol 73: 797-800.
42. Casazza J, Betts M, Picker L, Koup R (2001) Decay kinetics of human immunodeficiency virus-specific CD8+ T cells in peripheral blood after initiation of highly active antiretroviral therapy. J Virol 75: 6508-16.
43. Liu Y, Mullins J, Mittler J (2006) Waiting times for the appearance of cytotoxic T-lymphocyte escape mutants in chronic HIV-1 infection. Virology 347: 140-6.
44. Jung A, Maier R, Vartanian J, Bocharov G, Jung V, et al. (2002) Multiply infected spleen cells in HIV patients. Nature 418: 144.
45. Altfeld M, Allen T (2006) Hitting HIV where it hurts: an alternative approach to HIV vaccine design. Trends Immunol 27: 504-10.
46. Nowak M, Anderson R, McLean A, Wolfs T, Goudsmit J, et al. (1991) Antigenic diversity thresholds and the development of AIDS. Science 254: 963-9.
47. Press WH, Teukolsky SA, Vetterling WT, Flannery BP (1992) Numerical Recipes in C: The Art of Scientific Computing. New York, NY, USA: Cambridge University Press.
48. Gillespie D (1977) Exact stochastic simulation of coupled chemical reactions. The Journal of Physical Chemistry 81: 2340-2361.
49. Parera M, Fernandez G, Clotet B, Martinez M (2007) HIV-1 protease catalytic efficiency effects caused by random single amino acid substitutions. Mol Biol Evol 24: 382-7.
50. Mansky L, Temin H (1995) Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J Virol 69: 5087-94.